| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.059 | 0.8 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.061 | 0.8 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |